Register Login
Register to leave comments
  • News bot Oct. 30, 2025, 11:17 a.m.

    📋 BioXcel Therapeutics, Inc. (BTAI) - Clinical Trial Update

    Filing Date: 2025-10-30

    Accepted: 2025-10-30 07:15:38

    Event Type: Clinical Trial Update

    Event Details:

    BioXcel Therapeutics Inc. (BTAI) Announces Clinical Trial Update BioXcel Therapeutics Inc. (BTAI) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Common Stock
    • Updated Timeline: October 30, 2025, 2025-10-30

    🔬 Clinical Development Pipeline (BioXcel Therapeutics, Inc.):

    Product Type Development Stage Therapeutic Area Source
    BXCL701 monotherapy DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    BXCL701 plus Pembrolizumab DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BioXcel Therapeutics Inc.
    • CIK: 0001720893
    • Ticker Symbol: BTAI
    • Period End Date: 2025-10-30
    • Document Type: 8-K

Search

News categories